Cancer Phenotype Atlas
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
877
NCT05614011
Q-POC SARS-CoV-2 Assay COVID-19 Clinical Evaluation
Phase: N/A
Role: Collaborator
Start: Nov 28, 2022
Completion: May 17, 2023
Loading map...